With vaccine supply stretched thin, Brazil faces yellow fever outbreak
Brazil is experiencing a yellow fever epidemic in the face of a global...
Trending:
-
![]()
Early prostate cancer diagnosis: can Theresa May’s plan mimic results in Japan?
-
![]()
HPV vaccination rates nearly quadruple in American men
-
![]()
A growing antibiotic-resistant threat in the US
-
![]()
Burden of chronic lymphocytic leukemia is disproportionately higher in men
-
![]()
Can blockchain technology revolutionise healthcare data sharing?
-
![33111270506_6cdfd74444_k]()
FDA approves 23andMe at-home genetic test for breast cancer genes
Most Read
- With vaccine supply stretched thin, Brazil faces yellow fever outbreak
- Early prostate cancer diagnosis: can Theresa May’s plan mimic results in Japan?
- HPV vaccination rates nearly quadruple in American men
- Burden of chronic lymphocytic leukemia is disproportionately higher in men
- Can blockchain technology revolutionise healthcare data sharing?
Company A-Z
Latest Content
With vaccine supply stretched thin, Brazil faces yellow fever outbreak
Brazil is experiencing a yellow fever epidemic in the face of a global vaccine shortage.
Early prostate cancer diagnosis: can Theresa May’s plan mimic results in Japan?
On April 10, 2018, UK Prime Minister Theresa May announced a £75M (approximately $106M) investment into prostate cancer diagnosis and research. The plan aims to focus on early diagnosis in men in high-risk groups, including black men, men ages 50 and over, and men with a family history of the disease. The UK appears to be following the lead of Japan, where prostate cancer is typically diagnosed at an earlier stage compared with the other markets analysed by GlobalData.
The ageing population is at a greater risk of osteoporosis
Osteoporosis is a disease in which the density and quality of bone are reduced over time. Osteoporosis is often referred to as a ‘silent’ disease as the loss of bone occurs progressively, and often there are no symptoms until the first fracture occurs.
HPV vaccination rates nearly quadruple in American men
Human papillomavirus (HPV) is the most common sexually transmitted infection in the US.
A growing antibiotic-resistant threat in the US
Antimicrobial agents, which include antibiotics and similar drugs, have been used for the last 70 years to treat infectious diseases.
Burden of chronic lymphocytic leukemia is disproportionately higher in men
The burden of chronic lymphocytic leukaemia (CLL) is expected to grow in both men and women, ages 18 years and older, between 2015 and 2025 in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Canada). GlobalData epidemiologists forecast an increase in the number of diagnosed incident cases, most notably in men. Figure 1 presents the sex-specific cases of CLL in the 7MM in 2015.
The seven major markets face the growing burden of age-related macular edema
Age-related macular degeneration (AMD) is a progressive eye condition that causes the patient to gradually lose their central vision, which is used to focus the eye straight ahead.
Greiner Bio-One Releases New Issue of Customer Magazine bioLOGICAL
Greiner Bio-One is pleased to present the second edition of its customer magazine, bioLOGICAL.
Can blockchain technology revolutionise healthcare data sharing?
Blockchain is best known as the data-sharing technology behind cryptocurrencies such as Bitcoin and Etherium. However, there is increasing interest in how they can be used outside of cryptocurrency transactions to support the sharing of data within other industries. As medical technology develops, there is an increasing need to securely share an ever-growing volume of data between healthcare providers around the world. Industry leaders interviewed by GlobalData have highlighted blockchain as a solution.
FDA approves 23andMe at-home genetic test for breast cancer genes
Approximately 70% of women with a BRCA1 or BRCA2 gene mutation will develop breast cancer by the age of 80, according to a study published in 2017 in the Journal of the American Medical Association.
